United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News Is Apple’s conservative iPhone pricing strategy quietly eroding its long-term valuation? Needham warns Apple (NASDAQ: AAPL) may have lost up to 13 % in iPhone revenue by keeping prices flat. Discover why this could reshape its valuation. byPallavi MadhirajuOctober 5, 2025